세계의 관류 시스템 시장

Global Perfusion Systems Market to Reach US$1.6 Billion by 2030

The global market for Perfusion Systems estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$671.0 Million by the end of the analysis period. Growth in the Cell Perfusion Systems segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$336.0 Million While China is Forecast to Grow at 4.1% CAGR

The Perfusion Systems market in the U.S. is estimated at US$336.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$254.9 Million by the year 2030 trailing a CAGR of 4.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Perfusion Systems Market - Key Trends and Drivers Summarized

How Do Perfusion Systems Revolutionize Medical Procedures?

Perfusion systems play a crucial role in modern medical procedures by ensuring the effective delivery of oxygen and essential nutrients to tissues and organs during surgeries and other critical medical interventions. These systems are indispensable in cardiopulmonary bypass surgeries, organ transplantation, and various forms of intensive care. During open-heart surgery, for example, perfusion systems temporarily take over the function of the heart and lungs, maintaining blood circulation and oxygenation. This capability is vital for the success of complex surgical procedures and has significantly improved patient outcomes. Moreover, in organ transplantation, perfusion systems are used to preserve organs outside the body, extending the time available for transplantation and improving the viability of donor organs. The precision and reliability of perfusion systems have revolutionized the field of surgery and critical care, enabling more complex and life-saving procedures to be performed safely.

What Technological Innovations Are Shaping Perfusion Systems?

Technological innovations are at the forefront of advancements in perfusion systems, enhancing their efficiency, safety, and functionality. One notable development is the integration of advanced monitoring and control technologies, which allow for real-time assessment and adjustment of perfusion parameters. This ensures optimal perfusion conditions and reduces the risk of complications. Another significant innovation is the use of biocompatible materials and coatings in the construction of perfusion devices, which minimizes the risk of adverse reactions and enhances patient safety. Additionally, the advent of portable and minimally invasive perfusion systems has expanded their use beyond the operating room to include field hospitals and emergency settings. Advances in software and data analytics also enable more precise control and monitoring, improving outcomes in both surgical and non-surgical applications. These technological strides are making perfusion systems more versatile and effective, meeting the evolving needs of healthcare providers.

How Are Perfusion Systems Applied in Various Medical Fields?

Perfusion systems are applied across a broad spectrum of medical fields, each leveraging their capabilities to enhance patient care. In cardiovascular medicine, these systems are essential for procedures like coronary artery bypass grafting and valve replacement surgeries. In transplantation medicine, perfusion systems preserve and enhance the viability of organs such as kidneys, livers, and hearts, facilitating successful transplants and reducing waiting times. In oncology, perfusion systems are used in isolated limb perfusion techniques to deliver high doses of chemotherapy to specific areas, minimizing systemic side effects. Additionally, in critical care, extracorporeal membrane oxygenation (ECMO) is a life-saving application of perfusion technology, providing prolonged cardiac and respiratory support to patients with severe heart and lung conditions. The versatility and effectiveness of perfusion systems in these varied applications underscore their vital role in advancing medical treatment and patient outcomes.

What Factors Are Driving the Growth in the Perfusion Systems Market?

The growth in the perfusion systems market is driven by several factors. One of the primary drivers is the increasing prevalence of cardiovascular diseases and the rising demand for cardiac surgeries and interventions. The aging global population is also contributing to the market expansion, as older individuals are more likely to require surgeries that depend on perfusion systems. Technological advancements, such as the development of more sophisticated and portable perfusion devices, are further propelling market growth by expanding the range of applications and improving patient outcomes. Additionally, the growing emphasis on organ transplantation and the continuous improvement in organ preservation techniques are boosting the demand for perfusion systems. The expanding use of perfusion systems in emerging fields such as oncology and regenerative medicine is also a significant growth driver. As healthcare providers seek to enhance treatment efficacy and patient care, the demand for advanced perfusion systems is set to increase, ensuring robust market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Perfusion Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cardiopulmonary Perfusion Systems, Cell Perfusion Systems, EX Vivo Organ Perfusion System)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

• ALA Scientific Instruments, Inc.
• Getinge AB
• Harvard Bioscience, Inc.
• Lifeline Scientific, Inc.
• LivaNova PLC
• Medtronic PLC
• Merck KgaA
• Nipro Corporation
• Repligen Corporation
• Spectrum Laboratories, Inc.
• Terumo Corporation
• Xenios AG
• XVIVO Perfusion AB

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • Perfusion Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advances in Organ Preservation Technologies Propel Growth in Perfusion Systems Market
  • Increasing Demand for Minimally Invasive Surgical Procedures Strengthens Business Case for Perfusion Systems
  • Technological Innovations in Perfusion Pumps Accelerate Market Adoption
  • Rising Prevalence of Cardiovascular Diseases Spurs Demand for Perfusion Systems
  • Expansion of Organ Transplantation Procedures Generates Market Opportunities
  • Growing Investments in Healthcare Infrastructure Sustain Market Growth
  • Adoption of Portable and Compact Perfusion Systems Expands Addressable Market
  • Increasing Focus on Patient Safety and Outcome Improves Demand for Advanced Perfusion Systems
  • Regulatory Approvals and Compliance Requirements Propel Market Growth
  • Development of Smart Perfusion Systems with Real-Time Monitoring Throws Spotlight on Technological Advancements
  • Rising Geriatric Population Drives Demand for Cardiac Perfusion Systems
  • Increasing Number of Critical Care Units Drives Adoption of Perfusion Systems
  • Strategic Collaborations and Partnerships in Healthcare Sector Strengthen Market Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Cardiopulmonary Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Cardiopulmonary Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Cardiopulmonary Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Cell Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Cell Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Cell Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
  • TABLE 10: World Perfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for EX Vivo Organ Perfusion System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for EX Vivo Organ Perfusion System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for EX Vivo Organ Perfusion System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: USA 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: Canada 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• JAPAN
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: Japan 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• CHINA
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: China 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• EUROPE
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: Europe 15-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: Europe 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• FRANCE
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: France 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• GERMANY
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: Germany 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: Italy 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: UK 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Rest of Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Rest of Europe 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Asia-Pacific Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Asia-Pacific 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
• REST OF WORLD
  • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Rest of World Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Rest of World 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030

IV. COMPETITION